Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
BioSenic appoints Yves Sagot as Independent Director
BioSenic, the clinical stage company specializing in serious autoimmune/inflammatory diseases and cell repair, today announces […]
Kinnate Biopharma Adds Global Business and Oncology Expertise to Board of Directors
Kinnate Biopharma, a clinical-stage precision oncology company, has announced that its board of directors has […]
Nogra Pharma Announces Out-licensing Agreement with Torii Pharmaceutical for Japan for New Chemical Entity Topical Acne Treatment
Nogra Pharma, a clinical-stage biotechnology company developing innovative therapeutics for immune-inflammatory-mediated diseases, today announces it […]
Cerebral Therapeutics Names Julie Foster as Chief Operating Officer
Cerebral Therapeutics, a clinical-stage pharmaceutical company pioneering therapies for neurological diseases, announced today the appointment […]
ProPharma Acquires UK Based Digital Lab Consulting
ProPharma Group (ProPharma) the leading global provider of regulatory, clinical, and quality services for the […]
Crown Bioscience to Acquire Indivumed Service Business and Supporting Biobank
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, has […]
Blackford and Brainomix Announce AI Partnership for Stroke Care
Blackford, the pioneering strategic imaging AI platform and solutions provider, and Brainomix, the AI-powered medtech […]
Sysnav Healthcare Announces a Multi-year Collaboration with Roche
Sysnav Healthcare and Roche enter a partnership to facilitate development of industry-standard outcome measurements in […]
Aculys Pharma and Four H Initiate Research Collaboration using Wearable Devices to Study Sleep Disorders in Japan
Aculys Pharma, a company focused on the development and commercialization of new innovative drugs in […]
CytoSMART Technologies Joins the Axion BioSystems Brand
Axion BioSystems, a leader in live-cell analysis tools, today announced the full integration of imaging […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more